In Vitro Activities of Piperacillin against β-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 4, 2004, Pages 1229-1234

  Morikawa, Yoshiro ^a   Kitazato, Miyoshi ^a   Mitsuyama, Junichi ^b   Mizunaga, Shingo ^b   Minami, Shinzaburo ^b   Watanabe, Yasuo ^b  

^a YODOGAWA CHRISTIAN HOSPITAL   (Japan)

^b TOYAMA CHEMICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAMASE; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; PIPERACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BINDING AFFINITY; CELL KILLING; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOLYSIS; DRUG EFFICACY; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; PENICILLIN RESISTANCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STRAIN DIFFERENCE;

AMPICILLIN RESISTANCE; BACTERIAL PROTEINS; BETA-LACTAMASES; CARRIER PROTEINS; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORINS; HAEMOPHILUS INFLUENZAE; HEXOSYLTRANSFERASES; HUMANS; KINETICS; MENINGITIS, HAEMOPHILUS; MICROBIAL SENSITIVITY TESTS; MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE; PENICILLIN-BINDING PROTEINS; PENICILLINS; PEPTIDYL TRANSFERASES; PIPERACILLIN;

EID: 1642585734     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.4.1229-1234.2004     Document Type: Article

References (32)

1. Bijlmer, H. A., L. van Alphen, B. M. Greenwood, L. G. van den Broek, H. Á. Valkenburg, and J. Dankert. 1994. Antibiotic susceptibility of invasive and non-invasive isolates of Haemophilus influenzae from the Gambia, West Africa. J. Antimicrob. Chemother. 34:275-280.
2. Bottone, E., Z. Brandman, and S. S. Schneierson. 1976. Spheroplasts of Haemophilus influenzae induced by cell wall-active antibiotics and their effect upon the interpretation of susceptibility tests. Antimicrob. Agents Chemother. 9:327-333.
3. Campos, J., S. Garcia-Tornel, J. M. Gairi, and I. Fabregues. 1986. Multiple resistant Haemophilus influenzae type b causing meningitis: comparative clinical and laboratory study. J. Pediatr. 108:897-902.
4. Dickinson, G. M., D. G. Droller, R. L. Greenman, and T. A. Hoffman. 1981. Clinical evaluation of piperacillin with observations on penetrability into cerebrospinal fluid. Antimicrob. Agents Chemother. 20:481-486.
5. Doern, G. V., and the Alexander Project Collaborative Group. 1996. Antimicrobial resistance among lower respiratory tract isolates of Haemophilus influenzae: results of a 1992-93 Western Europe and USA collaborative surveillance study. J. Antimicrob. Chemother. 38:59-69.
6. Doern, G. V., A. B. Brueggemann, G. Pierce, H. P. Holley, and A. Rauch, Jr. 1997. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob. Agents Chemother. 41:292-297.
7. Doern, G. V., R. N. Jones, M. A. Pfaller, and K. Kugler. 1999. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob. Agents Chemother. 43:385-389.
8. Inui, T., T. Endo, and T. Matsushita. 2000. Morphological changes and lysis induced by β-lactams associated with the characteristic profiles of affinities of penicillin-binding proteins in Actinobacillus pleuropneumoniae. Antimicrob. Agents Chemother. 44:1518-1523.
9. Jacobs, M. R., S. Bajaksouzian, A. Zilles, G. Lin, G. A. Pankuch, and P. C. Appelbaum. 1999. Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. surveillance study. Antimicrob. Agents Chemother. 43:1901-1908.
10. Jorgensen, J. H., G. V. Doern, L. A. Maher, A. W. Howell, and J. A. Redding. 1990. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob. Agents Chemother. 34:2075-2080.
11. Jorgensen, J. H., L. A. Maher, and A. W. Howell. 1991. Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with β-lactamase- and non-enzyme-mediated resistance to ampicillin. Antimicrob. Agents Chemother. 35:600-602.
12. Kamiya, H., S. Uehara, T. Kato, K. Shiraki, T. Togashi, T. Morishima, Y. Goto, O. Satoh, and S. M. Standaert. 1998. Childhood bacterial meningitis in Japan. Pediatr. Infect. Dis. J. 17:S183-S185.
13. Malouin, F., and L. E. Bryan. 1988. Haemophilus influenzae penicillin-binding proteins 1a and 3 possess distinct and opposite temperature-modulated penicillin-binding activities. Antimicrob. Agents Chemother. 32:498-502.
14. Manninen, R., P. Huovinen, A. Nissinen, and the Finnish Study Group for Antimicrobial Resistance. 1997. Increasing antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Finland. J. Antimicrob. Chemother. 40:387-392.
15. Marco, F., J. Garcia-De-Lomas, C. Garcia-Rey, E. Bouza, L. Aguilar, and C. Fernandez-Mazarrasa. 2001. Antimicrobial Susceptibilities of 1, 730 Haemophilus influenzae Respiratory Tract Isolates in Spain in 1998-1999. Antimicrob. Agents Chemother. 45:3226-3228.
16. Matsuzaki, K., H. Koyama, K. Omika, M. Hasegawa, Y. Sato, I. Kobayashi, and A. Watanabe. 2000. Antibacterial activities of piperacillin for several resistant strains from respiratory infections - in reference to MRSA, PRSP, BLNAR and P. aeruginosa. Jpn. J. Antibiot. 53:566-572.
17. Mendelman, P. M., D. O. Chaffin, T. L. Stull, C. E. Rubens, K. D. Mack, and A. L. Smith. 1984. Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob. Agents Chemother. 26:235-244.
18. National Committee for Clinical Laboratory Standards. 1995. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
19. Nissinen, A., E. Herva, M. L. Katila, S. Kontiainen, O. L iimatainen, S. Oinonen, A. K. Takala, and P. Huovinen. 1995. Antimicrobial resistance in Haemophilus influenzae isolated from blood, cerebrospinal fluid, middle ear fluid and throat samples of children. A nationwide study in Finland in 1988-1990. Scand. J. Infect. Dis. 27:57-61.
20. Ohkusu, K., A. Nakamura, and K. Sawada. 2000. Antibiotic resistance among recent clinical isolates of Haemophilus influenzae in Japanese children. Diagn. Microbiol. Infect. Dis. 36:249-254.
21. Powell, M., and J. D. Williams. 1987. In vitro activities of aztreonam, imipenem, and amoxicillin-clavulanate against ampicillin-resistant Haemophilus influenzae. Antimicrob. Agents Chemother. 31:1871-1873.
22. Powell, M., D. McVey, M. H. Kassim, H. Y. Chen, and J. D. Williams. 1991. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Brahamella) catarrhalis isolated in the UK from sputa. J. Antimicrob. Chemother. 28:249-259.
23. Rittenhouse, S. F., L. A. Miller, R. L. Kaplan, G. H. Mosely, and J. A. Poupard. 1995. A survey of beta-lactamase-producing Haemophilus influenzae. An evaluation of 5750 isolates. Diagn. Microbiol. Infect. Dis. 21:223-225.
24. Scriver, S. R., D. J. Hoban, A. McGeer, T. C. Moore, S. L. Walmsley, and D. E. Low. 1994. Surveillance of susceptibility testing methodologies for Haemophilus influenzae in Canada, including evaluation of disk diffusion test. J. Clin. Microbiol. 32:2013-2015.
25. Seki, H., Y. Kasahara, K. Ohta, K. Ohta, Y. Saikawa, R. Sumita, A. Yachie, S. Fujita, and S. Koizumi. 1999. Increasing prevalence of ampicillin-resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan. Chemotherapy (Basel) 45:15-21.
26. Shisbido, H., and K. Matsumoto. 1979. Meningitis due to Haemophilus influenzae type e, biotype 4. J. Clin. Microbiol. 10:926-927.
27. Tamaki, S., S. Nakajima, and M. Matsuhashi. 1977. Thermosensitive mutation in Escherichia coli simultaneously causing defects in penicillin-binding protein-1Bs and in enzyme activity for peptidoglycan synthesis in vitro. Proc. Natl. Acad. Sci. USA 74:5472-5476.
28. Thornsberry, C., M. E. Jones, M. L. Hickey, Y. Mauriz, J. Kahn, and D. F. Sahm. 1999. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998. J. Antimicrob. Chemother. 44:749-759.
29. Tomasz, A. 1986. Penicillin-binding proteins and the antibacterial effectiveness of β-lactam antibiotics. Rev. Infect. Dis. 8:S260-S278.
30. Ubukata, K., Y. Shibasaki, K. Yamamoto, N. Chiba, K. Hasegawa, Y. Takeuchi, K. Sunakawa, M. Inoue, and M. Konno. 2001. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob. Agents Chemother. 45:1693-1699.
31. Yousif, S. Y., J. K. Broome-Smith, and B. G. Spratt. 1985. Lysis of Escherichia coli by β-lactam antibiotics: deletion analysis of the role of penicillin-binding proteins 1A and 1B. J. Gen. Microbiol. 131:2839-2845.
32. Zhao, G., T. I. Meier, S. D. Kahl, K. R. Gee, and L. C. Blaszczak. 1999. Bocillin FL, a sensitive and commercially available reagent for detection of penicillin-binding proteins. Antimicrob. Agents Chemother. 43:1124-1128.